← Eichor
Condition: Genetics Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Genetics Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors
Phase N/A · 1 location(s) · Lukas Vanek · NCT06680791Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Phase N/A · 1 location(s) · Brigham and Women's Hospital · NCT01177618International Cardiac Amyloidosis Registry
Phase N/A · 6 location(s) · Leiden University Medical Center · NCT06894290guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing
NA · 3 location(s) · Columbia University · NCT07610590Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1/Phase 2 · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06648096Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
Phase 2/Phase 3 · 5 location(s) · Masahisa Katsuno · NCT06862596DFT383 in Pediatric Participants With Nephropathic Cystinosis
Phase 1/Phase 2 · 4 location(s) · Novartis Pharmaceuticals · NCT06910813Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MY
Phase 1/Phase 2 · 10 location(s) · Tenaya Therapeutics · NCT05836259A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07517250Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Phase 1/Phase 2 · 4 location(s) · Arkansas Children's Hospital Research Institute · NCT07252050Personalised HeartCare: Poligenic Risk Scores Disclosure for Cardiovascular Prevention
NA · 1 location(s) · Catholic University of the Sacred Heart · NCT06888466A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN,
Phase N/A · 32 location(s) · argenx · NCT06078553Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
Phase 4 · 1 location(s) · Columbia University · NCT05919797Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04645160Cerebral Oxygen Metabolism in Children
NA · 1 location(s) · Washington University School of Medicine · NCT04157179Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulato
Phase 3 · 1 location(s) · Indiana University · NCT06996951Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys
Phase 4 · 1 location(s) · Runhui WU · NCT06864975Spanish Wilson Disease Registry
Phase N/A · 1 location(s) · Asociación Española para el Estudio del Hígado · NCT06466291Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
Phase N/A · 4 location(s) · Children's Hospital of Philadelphia · NCT04338048Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in
Phase N/A · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07278843Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT04613089A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510Genetic Profile In Patients With Ruptured and Unruptured Intracranial Aneurysms
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT07233915Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
NA · 2 location(s) · Hebrew SeniorLife · NCT06821568Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
NA · 33 location(s) · University of Washington, the Collaborative Health Studies C · NCT06654752Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease
NA · 2 location(s) · Meyer Children's Hospital IRCCS · NCT07375940Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06774989Natural History Study of Patients With Hypophosphatasia (HPP)
Phase N/A · 1 location(s) · Duke University · NCT02237625PET Imaging of Inflammation and Lipid Lowering Study
NA · 1 location(s) · University of Cambridge · NCT04073797Oral Ketamine for Treatment of Vaso-Occlusive Pain
Phase 3 · 1 location(s) · Boston Children's Hospital · NCT05378555
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.